Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for Readmission Following Autologous Stem Cell Transplant for Lymphoma and.

Similar presentations


Presentation on theme: "The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for Readmission Following Autologous Stem Cell Transplant for Lymphoma and."— Presentation transcript:

1 The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma by Samantha M. Jaglowski, Craig C. Hofmeister, Patrick Elder, Sam Penza, Yvonne A Efebera, Don M. Benson, Steven M. Devine, and Leslie A Andritsos Blood Volume 120(21): November 16, 2012 ©2012 by American Society of Hematology

2 Overall survival by readmission within 100 days.
Samantha M. Jaglowski et al. Blood 2012;120:4286 ©2012 by American Society of Hematology


Download ppt "The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for Readmission Following Autologous Stem Cell Transplant for Lymphoma and."

Similar presentations


Ads by Google